C-Better Technologies Prepares Provisional Telehealth Patent Filing/Acquires Telemedicine Patent

SACRAMENTO, Calif. - April 6, 2015 - PRLog -- Richard Shreiber, CEO of newly formed C-Better Technologies, announced that the company is ready to come out of stealth mode and begin raising seed capital to start production of prototypes and testing of several new telehealth initiatives aimed at bridging the gap between home patients and caregivers.

C-Better is developing new products that allow both visual and physiological data telemetry to be sent to doctors, managed care organizations, and real-time teleheath services before, during, or after the consult. "Giving telehealth doctors access to vital stats during a consult is a key component to ensuring proper treatment", according to Shreiber, "Everyone is focused on X-prize sci-fi technology that's really 5 years or more away. What we need are simple solutions that can be used now to move the whole industry forward. Our products combine off the shelf technologies with new analytics so we can bring these to market extremely fast with little or no need for FDA clearance."

The first products are focused both on general telehealth and the diabetes telehealth markets. These products allow patients in the comfort of their home to monitor their situation and, if necessary, capture and send this data to a physician or other service for review to determine if additional steps or treatments should be done. With millions of people still uninsured or paying out of pocket with high deductible plans, telehealth offers advantages both in time-savings and real costs over traditional office visits. Products that improve overall diagnosis, are low cost and can be used at home will be vital to the success of telehealth as a whole.

In the case of their Diabetes product, the goal is to catch early stage decubitus ulcers and foot wounds in patients with peripheral neuropathy (loss of sensation in feet and hands) before they result in serious infection and possible loss of limbs. Amputations are one of the largest cost drivers in the care of older diabetic patients as well as leading to high rates of mortality. The devices can leverage both patient-specific information as well as big data analytics to eventually allow computer algorithms to detect problems far earlier than the patient themselves can.

Shreiber also confirmed that a patent, recently awarded from his work while at FLIK Data Technologies (a cellular telehealth data company) has been licensed to C-Better Technologies. "This patent could have far reaching implications for other telemedicine companies looking to use cellular technology to transmit patient data. It's one of the few patents awarded in this area".

C-Better Technologies is now looking for initial round funding so they can, as Shreiber puts it: "get these devices off the drawing board and into the hands of the people who need them."

Interested investors should contact Mr. Shreiber directly at the information provided below.